2/10/2014 10:10:09 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics, Inc. a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its proprietary Stapled Peptide drug platform, today announced that Joseph Yanchik III, Chief Executive Officer of Aileron Therapeutics, will present at the Leerink Global Healthcare Conference on Wednesday, February 12th at 11:30a.m. EST at the Waldorf Astoria Hotel in New York.
Help employers find you! Check out all the jobs and post your resume.
comments powered by